Cochlear | COH - Beneficio Operativo

Precio De Mercado
169.79
Cambio Diario
-2.21 -1.28%
Mensual
-2.25%
Anual
-34.95%
Q2 Expectativa
168.61




Beneficio Operativo Cambio Fecha
Ansell USD 146.5M 87.85M 2025-12
Avita Medical AUD -10.41M 742K 2025-12
Cochlear AUD 261.1M 135.55M 2025-12
CSL USD 2.64B 1.97B 2025-12
Fisher Paykel Healthcare NZD 298.2M 2.8M 2025-12
Healius AUD -22.6M 47.5M 2024-12
Integral Diagnostics AUD 19.28M 73.95M 2024-06
Mayne Pharma AUD -3.3M 15.67M 2024-06
Mesoblast USD -30.96M 11.14M 2025-12
Monash IVF AUD 18M 10.11M 2025-12
Nanosonics AUD 9.12M 3.82M 2025-12
Polynovo AUD 2.06M 1.18M 2025-12
Ramsay Health Care AUD 541.1M 3.9M 2025-12
Regis Healthcare AUD 24.67M 11.91M 2025-12
ResMed USD 500.3M 37.95M 2025-12
Sigma Healthcare AUD 809K 13.76M 2024-12
Somnomed AUD -4.16M 1.28M 2023-06
Sonic Healthcare AUD 435.76M 193.66M 2024-12
Telix Pharmaceuticals AUD 8.04M 3.21M 2025-12